Navigation Links
Orthopedic Surgeon, Dr. Mark McFarland, Completes Milestone Case With NanoFUSE® Biologics Technology

NanoFUSE Biologics announced today that Dr. Mark McFarland completed his 50th case using NanoFUSE Biologics. The operation took place on Thursday, March 28, 2019 at Mary Immaculate Hospital in Newport News, Virginia. Dr. McFarland performed a posterior lumbar interbody fusion and removal of hardware on a 71-year-old male patient.

NanoFUSE Biologics is the only bioactive glass that is FDA-cleared to be combined with demineralized bone matrix (DBM). Bioactive glass has been clinically proven in orthopedics for over 30 years. NanoFUSE Biologics has now created a revolutionary and patented biologic using bioactive glass.

“The patented NanoFUSE manufacturing process produces an advanced bioactive glass/DBM combination with high efficacy that has been demonstrated in animal studies,” states NanoFUSE President, Jake Lubinski. “We’re excited about the growing surgeon adoption of NanoFUSE across all orthopedic practices, not just spine. To date, it has been used by over 300 surgeons and implanted in over 1200 patients.”

Dr. McFarland noted, “I’ve been excited to use NanoFUSE Biologics for its osteoinductive and osteoconductive properties which aids in the healing process. I’ve used NanoFUSE in my cervical and lumbar cases along with orthopedic applications outside of spine, and I’ve been pleased with the results."

Prior to undergoing surgery with Dr. McFarland, the patient had a previous fusion at L3-5 and experienced chronic pain since his initial surgery. Over time, the pain in his right and left gluteus made it increasingly difficult to stand or walk. After failing conservative treatments, including pain management and epidural injections, he opted for surgery. Lumbar X-rays revealed degenerative disc disease at L2-3 and L5-S1, and his MRI showed moderate central and lateral recess stenosis at L2-3 and 5-1. The patient demonstrated weakness and radiculopathy in both lower extremities. The patient is in good health after his procedure.

About NanoFUSE
NanoFUSE is the synergistic blend of osteoinductive DBM combined with the osteostimulative properties of bioactive glass. NanoFUSE is the only FDA-cleared combination of DBM and bioactive glass and is indicated for use in all orthopedic surgery. NanoFUSE Biologics is a KICVentures portfolio company.

Read the full story at

Source: PRWeb
Copyright©2019 Vocus, Inc.
All rights reserved

Related medicine technology :

1. Ethiopian-Born Neurosurgeon Dr. Fassil Mesfin and Orthopedic Surgeon Dr. Addisu Mesfin Thank KICVentures for Sponsoring Their Successful Mission Trip to Ethiopia
2. Elevate Your Comfort: Everlasting Comfort® Delivers Versatile Orthopedic Seat Cushion on Amazon
3. University Orthopedics and The Center for Orthopaedics Announce Partnership
4. St. Joseph’s Medical Center Partners with Dynafios to Launch Comprehensive Orthopedic and Spine Program
5. Dr. Brian Gengler, Spine Surgeon, Joins Precision Orthopedics & Sports Medicine
6. OrthoAtlanta is Official Orthopedic and Sports Medicine Provider to Atlanta Football Host Committee for 2018 College Football Playoff National Championship
7. Orthopedic Bone Cement - Medical Devices Pipeline Assessment, 2017
8. Research and Markets - Global Orthopedic Surgical Robots Market to Grow at a CAGR of 46%, 2017-2021 with OMNI, Smith & Nephew, Stryker & THINK Surgical Leading the Way
9. Orthopedic Navigation Systems Market to Reach $303.7 Million by 2025 - Increasing Geriatric Population Prone to Orthopedic Diseases - Research and Markets
10. Medeon Biodesign Announces Investing in Panther Orthopedics for Orthopedic Extremity Applications
11. Medeon Biodesign Announces Investing in Panther Orthorpedic for Orthopedic Extremity Applications
Post Your Comments:
(Date:6/20/2019)... ... , ... ERT, a global data and technology company that ... experts will present a series of innovative and educational live sessions and posters ... Diego, June 23-27. , ERT’s industry-recognized thought leaders will share their knowledge on ...
(Date:6/19/2019)... ... June 19, 2019 , ... Cardiovascular ... 31 percent of all global deaths (17.9 million per year), and are the ... developed to make care pathways, treatment and real-time visualization of cardiac anomalies and ...
(Date:6/19/2019)... , ... June 19, 2019 , ... One is never ... at the Los Angeles Jewish Home (LAJH). Known as a destination for Los Angeles-area ... including Edith Frankie, Linda Frankes, and Mildred Moccio, it is also a point of ...
Breaking Medicine Technology:
(Date:6/24/2019)... ... June 24, 2019 , ... ASRC ... Sustainment & Systems Integration Support (SSIS) contract. Awarded under the NITAAC CIO-SP3 Small ... and has a value of approximately $90 million. , The Data Network Technologies ...
(Date:6/20/2019)... ... June 20, 2019 , ... ... of Chicago Pacific Founders, announced a strategic partnership with Northern Westchester Ophthalmology, P.C. ... SightMD’s leading position in New York, adding the Company’s first location in Westchester ...
(Date:6/19/2019)... ... June 19, 2019 , ... Today, ... and government joined Global Health Council (GHC) and Global Water 2020 at ... water, sanitation, and hygiene (WASH) in healthcare facilities. , During the ...
(Date:6/19/2019)... (PRWEB) , ... June 19, 2019 , ... ... today, showcasing progress made in 2018 by the Alliance and its partners. ... trends while featuring voices from across the clean cooking sector, including an entrepreneur ...
(Date:6/19/2019)... ... , ... Expanding its commitment to the welfare of children through its new ... for Caterina’s Club during its annual West Coast gala - Notte di Savoia ... donated for the Southern California-based charity from funds raised by the event. The grant ...
Breaking Medicine News(10 mins):